This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Antimicrobials and Resistance: Opportunities and Challenges
Organizer(s): Gautam Dantas and Jennifer A. Leeds
Date: October 29 - November 01, 2017
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Supported by the Directors' Fund
Summary of Meeting:
Antimicrobial-resistant (AMR) infections claim numerous lives around the globe annually. This problem is exacerbated by a steady increase in global antimicrobial use and abuse in the clinic and agriculture, and a dearth of novel antimicrobials making it to market. If these scenarios continue unchecked, AMR will cumulatively cost the global economy around 100 trillion dollars by 2050. This conference focuses on the latest work understanding and combatting AMR, including clinical perspectives on AMR diagnostics and management, translational academic perspectives on design of drug regimens and combinations that suppress AMR, pharma perspectives on recent successes and failures in novel antimicrobial development and clinical trials and basic science perspectives on the ecology and transmission of evolving AMR determinants. While these stakeholders are similarly motivated to identify and develop therapies to treat the exceptional, unmet medical need of worsening AMR, their spheres rarely overlap at scientific conferences, leading to communication barriers between subject matter experts. This conference attempts to address this challenge by engaging diverse global perspectives on these topics, including speakers and attendees from academic research, industrial drug development, and healthcare practice and policy.
Scholarship Deadline: June 27 2017
Discounted Abstract Deadline: June 27 2017
Abstract Deadline: July 27 2017
Discounted Registration Deadline: August 29 2017
We gratefully acknowledge additional support for this conference from:

ACS Infectious Diseases
Forge Therapeutics, Inc.Spero Therapeutics
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Achaogen

Entasis Therapeutics

Spero Therapeutics
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI134087-01
Funding for this conference was made possible (in part) by 1R13AI134087-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found